Guo M, Liu Y, Xu L, et al. Cardiovascular pharmacological effects of traditional Chinese medicine ginkgo: mechanisms and prospects. Scientia Sinica Vitae (Chin) 2014;44:543-550.

Kandiah N, Ong PA, Yuda T, et al. Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761®. CNS Neurosci Ther 2019;25:288-298.

National Health Commission of the People's Republic of China. National Essential Medicines List (2018 edition). http://www.nhc.gov.cn/ewebeditor/uploadfile/2018/10/20181025183346942.pdfhttp://www.nhc.gov.cn/ewebeditor/uploadfile/2018/10/20181025183346942.pdf.

National Healthcare Security Administration. National Medicine List for Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance (2019 Edition):Chinese Patent Medicine. (2019-08-20)[2020-10-20].http://www.nhsa.gov.cn/art/2019/8/20/art_37_1666.htmlhttp://www.nhsa.gov.cn/art/2019/8/20/art_37_1666.html.

Guo M, Zhang Q, Yan LP, et al. Flavonoids as the main active ingredients of single herbs and compound Chinese medicines and their pharmacological activity. J Shenyang Med Coll (Chin) 2018;20:558-561, 564.

Ude C, Schubert-Zsilavecz M, Wurglics M. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clin Pharmacokinet 2013;52:727-749.

van Beek TA, Montoro P. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.J Chromatogr A 2009;1216:2002-2032.

Lamant V, Mauco G, Braquet P, et al. Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from Ginkgo biloba. Biochem Pharmacol 1987;36:2749-2752.

Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China (2020, edition): Volume 1. Beijing:China Medical Science and Technology Press; 2020:434-436.

United States Pharmacopoeia Commission. United States Pharmacopoeia (2020 edition). 2020; USP. NF38:5038.

European Pharmacopoeia Commission. European Pharmacopoeia (10th edition). 2020:1451-1453.

National Medical Products Administration. National Drug Standards 2002; Ws3-227(Z-028) 2002z.

Liu AH, Zhang ZX. Effects of Ginkgo biloba Extract 50(GBE50) on the action potentials of papillary muscles in normal and ischemia model of guinea pigs. China J Chin Mater Med (Chin) 2010;35:2342-2345.

Lu S, Guo X, Zhao P. Effect of Ginkgo biloba extract 50 on immunity and antioxidant enzyme activities in ischemia-reperfusion rats. Molecules 2011;16: 9194-9206.

Qiao ZY, Huang JH, Ma JW, et al. Ginkgo biloba extract reducing myocardium cells apoptosis by regulating apoptotic related proteins expression in myocardium tissues. Mol Biol Rep 2014;41:347-353.

Liu A, Bao Y, Wang X, Zhang Z. Cardio-protection by Ginkgo biloba Extract 50 in rats with acute myocardial infarction is related to Na+-Ca2+ exchange. Am J Chin Med 2013;41:789-800.

Schneider R, Welt K, Aust W, et al. Cardiac ischemia and reperfusion in spontaneously diabetic rats with and without application of EGb761: Ⅰ. Cardiomyocytes. Histol Histopathol 2008;23:807-817.

Liu Y, Liu YF, Tian JF, et al. Cardiovascular protection mechanism of Ginkgo biloba extract on a rat model of type 2 diabetes after myocardial infarction. Chin J Integr Tradit West Med (Chin) 2017;37:1100-1104.

Tsai JY, Su KH, Shyue SK, et al. EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovasc Res 2010;88:415-423.

Lim S, Yoon JW, Kang SM, et al. EGb761, a Ginkgo biloba Extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One 2011;6:e20301.

Tsai HY, Huang PH, Lin FY, et al. Ginkgo biloba Extract reduces high-glucose-induced endothelial reactive oxygen species generation and cell adhesion molecule expression by enhancing HO-1 expression via Akt/eNOS and p38 MAP kinase pathways. Eur J Pharm Sci 2013;48:803-811.

Zhu GY, Zhu W, Pan LY, et al. Effect of Ginkgo biloba Tablets on the expression of scavenger receptor A on in the aortic wall of atherosclerotic rats. Chin J Integr Tradit West Med (Chin) 2016;36:449-453.

Xu ZB, Wang WD, Zhang LF, et al. Experimental study on the intervention of Ginkgo biloba Capsules on the apoptosis of vascular endothelial cells in hyperhomocysteinemia. Chin J Integr Tradit West Med (Chin) 2015;35:1099-1104.

Sun WJ, Sun J, Chen BD, et al. Ginkgolide B inhibits hyperglycemia-induced TLR4 and inflammatory protein expression in endothelial cells. Chin Pharmacol Bull (Chin)2015;31:636-640.

Li M, Bao YM, Liu AH, et al. Effect of Ginkgo biloba Extract 50 on ventricular remodeling in pressure-overloaded rats.Pharmacol Clin Chin Mater Med (Chin) 2013;29:78-82.

Jiang H, Qu P, Cui XQ, et al. Effect of Ginkgo biloba Extract 50 on TLR4/NF-κB signaling mediated expression of angiotensinogene and angiotensin Ⅱ type Ⅰ receptor in cardiomyocytes. Chin J Hypertens (Chin) 2008;16:1013-1017.

Liu MY, Zhang LJ. Regulatory effect of Ginkgo biloba extract on 5-hydroxytryptamine and its receptors in mice with heart failure. Chin Med J (Chin) 2018;98:2024-2029.

Cho JH, Sung JH, Cho EH, et al. Gingko biloba Extract (EGb 761) prevents ischemic brain injury by activation of the Akt signaling pathway. Am J Chin Med 2009;37:547-555.

Sung JH, Shah FA, Cho EH, et al. Ginkgo biloba Extract (EGb 761) prevents the ischemic brain injury-induced decrease in parvalbumin expression. Lab Anim Res 2012;28:77-82.

Nada SE, Tulsulkar J, Shah ZA. Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba(EGb 761®) after permanent ischemic stroke in mice. Mol Neurobiol 2014;49:945-956.

Tulsulkar J, Glueck B, Hinds TD, et al. Ginkgo biloba extract prevents female mice from ischemic brain damage and the mechanism is independent of the HO1/Wnt pathway. Transl Stroke Res 2016;7:120-131.

Tulsulkar J, Shah ZA. Ginkgo biloba prevents transient global ischemia-induced delayed hippocampal neuronal death through antioxidant and anti-inflammatory mechanism. Neurochem Int 2013;62:189-197.

Zhang Z, Peng D, Zhu H, et al. Experimental evidence of Ginkgo biloba extract EGb as a neuroprotective agent in ischemia stroke rats. Brain Res Bull 2012;87:193-198.

Yuan R, Zhang YH, Cheng BL, et al. Effect of Ginkgo biloba extract 50 (EGb50) on the mitochondrial function of SH-SY5Y cells after hypoxia/reoxygenation injury. China J Chin Mater Med (Chin) 2018;43:4486-4490.

Hao L, Xu YY, Ren XH, et al. Effects of Ginkgo biloba Extract 50 on learning and memory in naturally aging rats and the expressions of c-fos, caspase-3 and caspase-8 in the hippocampus and prefrontal cortex. Pharmacol Clin Chin Mater Med (Chin) 2015;31:96-100.

Xia CY, Dong XW, Zhao Y, et al. Experimental study on the effects of Ginkgo biloba Extract 50 on cell damage caused by β-amyloid-induced oxidative stress in rat hippocampal neurons. Chin J Integr Tradit West Med (Chin)2014;34:833-838.

Liu FQ, Gao Q, Wang DD, et al. Effects of Gingko Biloba Extract 50 on depression-like behavior and NLRP3 inflammasome in depressed rats. Acad J Shanghai Univ Tradit Chin Med (Chin) 2017;31:60-65.

He DF, Zhang LJ, Liu MY. Effects of drug treatment on sleep in zebrafish with insomnia and related mechanisms. Chin J Evid Based Cardiovasc Med (Chin) 2017;9:326-330.

Zhang L, Liu J, Ge Y, et al. Ginkgo biloba Extract reduces hippocampus inflammatory responses, improves cardiac functions and depressive behaviors in a heart failure mouse model. Neuropsychiatr Dis Treat 2019;15:3041-3050.

Sun T, Wang X, Xu H. Ginkgo biloba extract for angina pectoris: a systematic review. Chin J Integr Med 2015;21:542-550.

Chen H, Feng S, Chen HP, et al. Efficacy and safety of Ginkgo biloba Drop Pills in the treatment of angina: a systematic review of randomized controlled trials. Chin J New Drugs (Chin) 2019;28:2291-2298.

Zhao MJ, Ma LL, Li BF, et al. Systematic review and meta-analysis on the effectiveness of Ginkgo biloba Drop Pills combined with antihypertensive drugs in the treatment of primary hypertension. Chin J Evid Based Cardiovasc Med(Chin) 2019;11:910-913.

Chen H, Zhou C, Yu M, et al. The effect of Ginkgo biloba Dropping Pills on hemorheology and blood lipid:a systematic review of randomized trials. Evid Based Complement Alternat Med 2019;2019:2609625.

Song SQ, Wu YQ, Deng ZW, et al. Effect of Ginkgo biloba preparations on carotid artery ultrasound-related parameters in patients with carotid atherosclerosis.Pharmacol Clin Chin Mater Med (Chin) 2008;3:106-108.

Li S, Zhang X, Fang Q, et al. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial. Stroke Vasc Neurol 2017;2:189-197.

Chong PZ, Ng HY, Tai JT, et al. Efficacy and safety of Ginkgo biloba in patients with acute ischemic stroke: a systematic review and meta-analysis. Am J Chin Med 2020;48:513-534.

Aziz TA, Hussain SA, Mahwi TO, et al. The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: a double-blind, randomized, placebo-controlled trial. Drug Des Dev Ther 2018;12:735-742.

An XF, Zhao Y, Yu JY. Clinical observations on the prevention and treatment of early retinopathy in type 1 diabetes mellitus with Liuwei Dihuang Pills combined with Ginkgo biloba Tablets. Chin J Integr Tradit West Med (Chin)2016;36:674-677.

Zheng WR, Han ZZ, Wang ZK, et al. Research advances in the safety Ginkgo biloba preparations. Modern Tradit Chin Med Mater Med–World Sci Tech (Chin) 2019;21:437-443.

National Medical Products Administration. Announcement of the National Medical Products Administration on Revising the Instructions for Oral Preparations of Ginkgo biloba.Available at: http://www.cdr-adr.org.cn/drug_1/aqjs_1/drug_aqjs_smssggg/202001/t20200113_47040.html 1http://www.cdr-adr.org.cn/drug_1/aqjs_1/drug_aqjs_smssggg/202001/t20200113_47040.html 1.